A Study to Evaluate the Efficacy and Safety of Dasotraline in Children 6 to 12 Years Old With Attention-Deficit Hyperactivity Disorder (ADHD) in a Simulated Classroom Setting.
Public ClinicalTrials.gov record NCT03231800. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Dasotraline (2mg) in Children Aged 6 to 12 Years With Attention-Deficit Hyperactivity Disorder (ADHD): A Randomized, Multicenter, Double-blind, Placebo-controlled, Parallel-group Study of Efficacy and Safety in a Laboratory Classroom Setting
Study identification
- NCT ID
- NCT03231800
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Sumitomo Pharma America, Inc.
- Industry
- Enrollment
- 95 participants
Conditions and interventions
Interventions
- dasotraline Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 6 Years to 12 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 30, 2017
- Primary completion
- Mar 14, 2019
- Completion
- Mar 14, 2019
- Last update posted
- Jul 7, 2020
2017 – 2019
United States locations
- U.S. sites
- 8
- U.S. states
- 6
- U.S. cities
- 8
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Avida Inc | Newport Beach | California | 92660 | — |
| Meridien Research | Bradenton | Florida | 34201 | — |
| Meridien Research | Maitland | Florida | 32751 | — |
| Qps-Mra, Llc | South Miami | Florida | 33134 | — |
| South Shore Psychiatric Services PC | Hingham | Massachusetts | 02043 | — |
| Center for Psychiatry and Behavioral Medicine, Inc | Las Vegas | Nevada | 89128 | — |
| Bayou City Research, Ltd | Houston | Texas | 77007 | — |
| Ericksen Reasearch and Development | Clinton | Utah | 84015 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03231800, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 7, 2020 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03231800 live on ClinicalTrials.gov.